Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 585

1.

Bronchopulmonary dysplasia in preterm infants: pathophysiology and management strategies.

D'Angio CT, Maniscalco WM.

Paediatr Drugs. 2004;6(5):303-30.

PMID:
15449969
2.

Bronchopulmonary dysplasia.

Deakins KM.

Respir Care. 2009 Sep;54(9):1252-62.

3.

[From classic to new bronchopulmonary dysplasia].

Kramer BW, Lievense S, Been JV, Zimmermann LJ.

Ned Tijdschr Geneeskd. 2010;154:A1024. Review. Dutch.

PMID:
20456770
4.

Pathogenesis of bronchopulmonary dysplasia.

Chess PR, D'Angio CT, Pryhuber GS, Maniscalco WM.

Semin Perinatol. 2006 Aug;30(4):171-8. Review.

PMID:
16860156
5.

Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.

Bassler D.

Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5. Review.

PMID:
26044104
6.

[Bronchopulmonary dysplasia].

Clément A.

Rev Mal Respir. 1996 Jul;13(3):243-9. Review. French.

PMID:
8765916
7.

Pathophysiology and treatment of bronchopulmonary dysplasia. Current issues.

Abman SH, Groothius JR.

Pediatr Clin North Am. 1994 Apr;41(2):277-315. Review.

PMID:
8139877
8.
9.

Ventilatory management and bronchopulmonary dysplasia in preterm infants.

Gupta S, Sinha SK, Donn SM.

Semin Fetal Neonatal Med. 2009 Dec;14(6):367-73. doi: 10.1016/j.siny.2009.08.011. Epub 2009 Sep 17. Review.

PMID:
19766071
10.

Pathogenesis of bronchopulmonary dysplasia.

Hayes D Jr, Feola DJ, Murphy BS, Shook LA, Ballard HO.

Respiration. 2010;79(5):425-36. doi: 10.1159/000242497. Epub 2009 Sep 25. Review.

PMID:
19786727
11.
12.

[The use of postnatal corticosteroid therapy in premature infants to prevent or treat bronchopulmonary dysplasia: current situation and recommendations].

Jarreau PH, Fayon M, Baud O, Autret-Leca E, Danan M, de Verdelhan A, Castot A.

Arch Pediatr. 2010 Oct;17(10):1480-7. doi: 10.1016/j.arcped.2010.07.013. Epub 2010 Sep 22. French.

PMID:
20864322
13.

[Glucocorticoide therapy in premature infants: French practices in 2006].

Autret-Leca E, Bauer S, Alberti C, Jonville-Béra AP, Aujard Y, Bensouda-Grimaldi L, Baud O.

Arch Pediatr. 2009 Jul;16(7):999-1004. doi: 10.1016/j.arcped.2009.03.013. Epub 2009 May 1. French.

PMID:
19410441
14.

Antenatal steroids and risk of bronchopulmonary dysplasia: a lack of effect or a case of over-adjustment?

Gagliardi L, Bellù R, Rusconi F, Merazzi D, Mosca F.

Paediatr Perinat Epidemiol. 2007 Jul;21(4):347-53.

PMID:
17564592
15.

Bronchopulmonary dysplasia and surfactant.

Bancalari E, del Moral T.

Biol Neonate. 2001 May;80 Suppl 1:7-13.

PMID:
11359038
16.

Nonventilatory strategies for prevention and treatment of bronchopulmonary dysplasia--what is the evidence?

Thomas W, Speer CP.

Neonatology. 2008;94(3):150-9. doi: 10.1159/000143719. Epub 2008 Aug 1. Review.

PMID:
18679037
17.

Ventilatory strategies in the prevention and management of bronchopulmonary dysplasia.

Ambalavanan N, Carlo WA.

Semin Perinatol. 2006 Aug;30(4):192-9. Review.

PMID:
16860159
18.

Postnatal hydrocortisone for preventing or treating bronchopulmonary dysplasia in preterm infants: a systematic review.

Doyle LW, Ehrenkranz RA, Halliday HL.

Neonatology. 2010;98(2):111-7. doi: 10.1159/000279992. Epub 2010 Feb 12. Review.

19.
20.

Long-term pulmonary outcome in the preterm infant.

Greenough A.

Neonatology. 2008;93(4):324-7. doi: 10.1159/000121459. Epub 2008 Jun 5. Review.

PMID:
18525217
Items per page

Supplemental Content

Write to the Help Desk